Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7)

Plastic and Reconstructive Surgery

Volumn 111, Issue 3, 2003, Pages 1195-1206

  Rodgers, Kathleen E ^a   Espinoza, Theresa ^a   Felix, Juan ^a   Roda, Norma ^a   Maldonado, Sonia ^a   DiZerega, Gere ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 7 RECEPTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][3 NORLEUCINE]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; BECAPLERMIN; PLACEBO; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; LONG TERM CARE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SCAR FORMATION; SKIN FIBROSIS; SKIN INCISION; SKIN SCAR; TISSUE REPAIR; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANGIOTENSIN II; ANIMALS; CICATRIX; FEMALE; MICE; MICE, INBRED NOD; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; WOUND HEALING;

EID: 0037334640     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000047403.23105.66     Document Type: Article

References (17)

1. Rodgers, K. E., Abiko, M., Girgis, W., St. Amand, K., Campeau, J., and diZerega, G. S. Acceleration of dermal tissue repair by angiotensin II. Wound Repair Regen. 5: 175, 1997.
2. Rodgers, K. E., DeCherney, A. H., St. Amand, K., et al. Histologic alterations in dermal repair after thermal injury: Effects of topical angiotensin II. J. Burn Care Rehabil. 18: 381, 1997.
3. Okuyama, N., Roda, N., Sherman, R., et al. Angiotensin II improves random-flap viability in a rat model. Ann. Plast. Surg. 42: 313, 1999.
4. Rodgers, K. E., Xiong, S., Felix, J., et al. Development of angiotensin(1-7) as an agent to accelerate dermal repair. Wound Repair Regen. 9: 238, 2001.
5. Daemen, M. J., Lombardi, D. M., Bosman, F. T., and Schwartz, S. M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 68: 450, 1991.
6. Dzau, V. J., Pratt, R., Gibbons, G., Schunkert, H., Lorell, B., and Ingelfinger, J. Molecular mechanism of angiotensin in the regulation of vascular and cardiac growth. J. Mol. Cell. Cardiol. 21 (Suppl. III): S7, 1989.
7. Kawahara, Y., Sunako, M., Tsuda, T., Fukazaki, H., Fukomoto, Y., and Takai, Y. Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 150: 52, 1988.
8. Koibuchi, Y., Lee, W. S., Gibbons, G. H., and Pratt, R. E. Role of transforming growth factor-β1 in the cellular growth response to angiotensin II. Hypertension 21: 1046, 1993.
9. Mangiarua, E. I., Palmer, V. L., Lloyd, L. L., and McCumbee, W. D. Platelet-derived growth factor mediates angiotensin II-induced DNA synthesis in vascular smooth muscle cells. Arch. Physiol. Biochem. 105: 151, 1997.
10. Naftilan, A. J., Pratt, R. E., and Dzau, V. J. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1419, 1989.
11. Nakahara, K., Nishimura, H., Kuro-o, M., et al. Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II. Biochem. Biophys. Res. Commun. 184: 811, 1992.
12. Stouffer, G. A., and Owens, G. K. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ. Res. 70: 820, 1992.
13. Su, E. J., Lombardi, D. M., Wiener, J., Daemen, M. J., Reidy, M. A., and Schwartz, M. A. Mitogenic effect of angiotensin II on the rat carotid arteries and type II or III mesenteric microvessels but not type I mesenteric microvessels is mediated by endogenous basic fibroblast growth factor. Circ. Res. 82: 321, 1998.
14. Temizer, D. H., Yoshizumi, M., Perrella, M. A., Susanni, E. E., Quertermous, T., and Lee, M. E. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem. 267: 24892, 1992.
15. Hollander, J. E., and Singer, A. J. Application of tissue adhesives: Rapid attainment of proficiency: Stony Brook Octylcyanoacrylate Study Group. Acad. Emerg. Med. 5: 1012, 1998.
16. Singer, A. J., Thode, H. C., Jr., and Hollander, J. E. Research fundamentals: Selection and development of clinical outcome measures. Acad. Emerg. Med. 7: 397, 2000.
17. Kramar, E. A., Armstrong, D. L., Ikeda, S., Wayner, M. J., Harding, J. W., and Wright, J. W. The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res. 897: 114, 2001.